Annovis Bio to Present Company’s Novel Approach to Treating Parkinson’s Disease at University of Pennsylvania
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, is pleased to announce its …
Read More